Back
Speaker illustration

Mrs Maiia Denysova

Bogomoletz Institute of Physiology, Kiev (Ukraine)

Maiia Denisova Kyiv, Ukraine BD: May 26, 1981 Married with two children 2020 The highest qualification category in the specialty "Cardiology" up to the present: Cardiologist at the Kiyv Hospital (admission,examination,treatment of cardiac patients(HF,AH,IHD) 2019 by now: Postgraduate study at the Bogomoletz Institute of Physiology, Department of Blood Circulation -writing of the dissertation "Ways of influence and the role of the mitochondrial pore in the restoration of cardiovascular system function in rats with anthracycline-induced heart failure" -area of expertise: the role of the mPTP in toxic injury of the myocardium; functional state of the heart after toxic damage Specialization in echocardiography(2016),in cardiology(2008),in anesthesiology and resusсitation(2006) 2004 Graduated from Bogomoletz NMU with a degree in General Medicine, diploma with honors Have a GCP certificate(2015-co-investigator in CT) English B1-B2 driver's license of category B

Presentations

Doxorubicin leads to increased oxidative stress and opening of the calcium-induced mitochondrial permeability transition pore

Event: Heart Failure 2024

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: ePosters in chronic heart failure - pathophysiology and mechanisms 2

Access
Thumbnail

Administration of doxorubicin increases the sensitivity of the mitochondrial permeability transition pore to calcium and causes pathological changes in the electrocardiography.

Event: Heart Failure 2023

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: ePosters in chronic heart failure - pathophysiology and mechanisms 2

Access
Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb